|
W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL
|
Back to Search Results |
|
| Catalog Number |
BXA067902A |
| Medical Device Problem Codes |
Obstruction of Flow (2423); Migration (4003)
|
| Health Effect - Clinical Code |
Obstruction/Occlusion (2422)
|
| Date of Event |
06/03/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.Manufacturer report # 2017233-2024-05131 was submitted for same patient and same procedure for two devices implanted as one unit in the superior mesenteric artery.A third report will be submitted for two devices implanted as one in the celiac artery.H6 - code b14: device manufacturing record history is currently being reviewed.H6 - code b20: devices remain implanted and images were not provided.Therefore, direct product analysis was not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
Information received from a clinical study: on (b)(6) 2022, the study patient was implanted with several gore® excluder® devices and a gore® excluder® thoracoabdominal branch endoprosthesis (tambe device).Gore® viabahn® vbx balloon expandable endoprosthesis (vbx device(s)) were also implanted as branch devices in the visceral vessels.Two vbx devices were implanted the superior mesenteric artery (sma), two vbx devices in the celiac artery, and one vbx device in the left renal artery.On june 3, 2024, graft leakage was reported for an aortic device.At this time, it was found the vbx devices lost seal in three vessels (celiac, sma, and left renal artery).An endoleak extending from inferior mesenteric artery (ima) was also observed.It was reported branch device patency had been lost.On the same day intervention was performed with balloon angioplasty and additional stents were implanted in the three vessels.At the end of procedure, the ima still had remaining endoleak.The patient tolerated the procedure.This report is for device implanted in the left renal artery.
|
| |
|
Additional Manufacturer Narrative
|
|
During this same procedure / same patient, additional vbx devices were implanted and found to have issues.Three manufacturer report was submitted: # 2017233-2024-05131 (superior mesenteric artery) and # 2017233-2024-05133 (celiac artery).One vbx device was implanted in the left renal artery.H6 - code c19: review of device manufacturing record history confirmed device met pre-release specifications.H6 - code b20: the device remains implanted, and no images were provided; therefore, direct product analysis was not possible.The ifu was reviewed and the following statement was found to be applicable: complications and adverse events can occur when using any endovascular device.These complications include, but are not limited to: stenosis, thrombosis or occlusion.
|
| |
|
Search Alerts/Recalls
|
|
|